These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 90138)
1. Urinary glycosaminoglycans in patients with progressive myoclonus epilepsy. Federico A; D'Auria N J Neurol; 1979 Jan; 220(4):291-5. PubMed ID: 90138 [TBL] [Abstract][Full Text] [Related]
2. Content and composition of urinary glycosaminoglycans in the patients with myoclonus epilepsy with and without Lafora bodies. Constantopoulos G; Dekaban AS; Steusing JK; Eldridge R Acta Neurol Scand; 1977 Oct; 56(4):291-8. PubMed ID: 200053 [TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of indican in progressive myoclonus epilepsy without Lafora bodies. The effect of sodium valproate. Koskiniemi M; Palo J J Neurol Sci; 1978 Dec; 39(2-3):235-9. PubMed ID: 105091 [TBL] [Abstract][Full Text] [Related]
4. Familial progressive myoclonic epilepsy. A clinical, genetical, biochemical and patho-anatomical study of a family with a 6-year follow-up. Pedersen E; Grynderup V; Kissmeyer-Nielsen F; Nielsen J; Poulsen JH; Reske-Nielsen E J Neurol Sci; 1982 Feb; 53(2):305-20. PubMed ID: 6276514 [TBL] [Abstract][Full Text] [Related]
6. Reassessment of phenytoin for treatment of late stage progressive myoclonus epilepsy complicated with status epilepticus. Miyahara A; Saito Y; Sugai K; Nakagawa E; Sakuma H; Komaki H; Sasaki M Epilepsy Res; 2009 Apr; 84(2-3):201-9. PubMed ID: 19268538 [TBL] [Abstract][Full Text] [Related]
7. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam. Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282 [TBL] [Abstract][Full Text] [Related]
8. The excretion patterns of urinary glucosaminoglycans in a family with progressive familial myoclonus epilepsy. Poulsen JH Acta Neurol Scand; 1975 Sep; 52(3):216-30. PubMed ID: 125520 [TBL] [Abstract][Full Text] [Related]
9. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy. Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951 [TBL] [Abstract][Full Text] [Related]
10. [Myoclonus and epilepsies in children]. Fejerman N Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607 [TBL] [Abstract][Full Text] [Related]
13. [Electrophysiogical and neuropharmacological studies in a patient with progressive myoclonus-epilepsy (author's transl)]. Rumpl E; Gerstenbrand F; Hengl W; Binder H EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1977 Jun; 8(2):77-81. PubMed ID: 408123 [TBL] [Abstract][Full Text] [Related]
14. Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug. Pranzatelli MR; Tate ED Pediatr Neurol; 2001 Nov; 25(5):385-9. PubMed ID: 11744313 [TBL] [Abstract][Full Text] [Related]
15. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Hurd RW; Wilder BJ; Helveston WR; Uthman BM Neurology; 1996 Nov; 47(5):1264-8. PubMed ID: 8909441 [TBL] [Abstract][Full Text] [Related]
17. Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases. Häusler M; Kluger G; Nikanorova M Neuropediatrics; 2011 Feb; 42(1):28-9. PubMed ID: 21557146 [TBL] [Abstract][Full Text] [Related]
18. Clinical and neuropsychological considerations in a case of unrecognized myoclonic epileptic jerks dramatically controlled by levetiracetam. Gentile V; Brunetto D; Leo I; Bonetti S; Verrotti A; Franzoni E Neuropediatrics; 2010 Dec; 41(6):270-2. PubMed ID: 21445819 [TBL] [Abstract][Full Text] [Related]
19. Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Mervaala E; Andermann F; Quesney LF; Krelina M Neurology; 1990 Jan; 40(1):53-6. PubMed ID: 2104965 [TBL] [Abstract][Full Text] [Related]